This document provides Technical content on ZIKV, its manifestations, complications, modes of transmission, and prevention measures to be used in answering frequently asked questions and conveying messages in information and communication materials, community talks, press conferences, etc.
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section... on traditional essential medicines list is also included at the end of the NEML
more
ECDC MISSION REPORT 19–21 September 2016 ; 14–15 November 2016
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...on and follow-up of children born to women living in areas of Zika virus transmission. The Guideline summarises the evidence base and rationale in support of the recommendations and expands the scope to address complications beyond microcephaly and what is now referred to as the congenital Zika virus syndrome
more
Mission report: June 11-20, 2017
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
Multilingual guide on the topic of protective vaccination for migrants in Germany.
The guide is available in 16 languages: Albanian, Arabic, Bulgarian, German, English, French,
Greek, Italian, Kurdish, Persian, Polish, Romanian,
Russian, Serbian, Croatian, Spanish, Turkish. For the versions i...n other languages go to http://www.ethno-medizinisches-zentrum.de/index.php?option=com_content&view=article&id=37&Itemid=40
more
WHO Secretariat Information paper July 2016
BMC Medicine201614:112 DOI: 10.1186/s12916-016-0660-0
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Manual of Operations
First Edition 2016